002001 Zhejiang Nhu
- 19.77
- +0.13+0.66%
Zhejiang Nhu News
Shin Hesung (002001): Rising vitamin prices are optimistic about the recovery of the economy
Research Report: Bank of China Securities: Maintaining Shinhecheng's “Buy” Rating, Optimistic About Performance Growth Driven by Rising Vitamin and Methionine Prices
Xinhecheng (002001): Vitamin and methionine prices rise, new projects continue to advance
Xinhecheng (002001): Performance is in line with expectations, the nutrition sector bottomed out and rebounded, and the “Chemical+” and “Bio+” platforms expanded steadily
Xinhecheng (002001): Vitamin prices are gradually picking up, and methionine projects are expected to expand
Xinhecheng (002001): Improving performance in terms of prices of major products in Q1 and investing in new production capacity to lead growth
Xinhecheng (002001): Net profit attributable to 23 billion yuan decreased by 25.30% year-on-year, optimistic about the growth brought about by the commissioning of new projects
Xinhecheng (002001) Company Annual Report Review: Net profit attributable to 23 billion yuan of 2.704 billion yuan fell 25.30% year-on-year, optimistic about the growth brought about by the commissioning of new projects
Xinhecheng (002001) 2024 Quarterly Report Review: The sharp rise in methionine volume and price to help improve performance. Vitamin inflection point is now expected to begin recovery
Xinhe Cheng (002001): The sharp rise in methionine volume and price drives growth, 1Q24 results are in line with expectations
Xinhecheng (002001): The sharp rise in the quantity and price of methionine helped to significantly improve Q1 performance and the orderly release of projects under construction to drive medium- to long-term growth
Shinhecheng (002001): Global leader in vitamin integration, methionine business accelerates growth
Xinhe Cheng (002001): Performance is in line with expectations, and the boom in core nutritional products is picking up
Shin Hesung (002001): Significant improvement in performance, abundant production capacity under construction
Xinhecheng (002001): The quantity and price of methionine rose sharply, ushered in a good start in the first quarter
Xinhecheng (002001): Q1 profit improved month-on-month, and the nutrition market recovered
Shinhecheng (002001): Methionine and vitamin boom picked up, Q1 performance improved markedly
Guohai Securities released a research report on April 25 stating that it gave Xinhecheng (002001.SZ) a purchase rating. The main reasons for the rating include: 1) the company's 2023 performance declined year-on-year due to narrowing profits from nutritio
Xinhe Cheng (002001): Q1 performance improved significantly year-on-year, and business continued to expand in the four major sectors
Huaan Securities released a research report on April 24 stating that it gave Xinhecheng (002001.SZ) a buying rating. The main reasons for the rating include: 1) the company's performance for the full year of 23 was in line with expectations, with signific
Analysis
Price Target
No Data
